This observation was supported neither by our study nor by the meta-analysis that included 25,685 subjects that suggested that the TLR9 rs352140 and rs5743836 SNPs were associated with a decreased risk of development of breast and digestive system cancers [34]. This evidence concerns the gene TLR9 and digestive system cancer.